{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:24:56Z","timestamp":1785385496378,"version":"3.55.0"},"reference-count":69,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1210\/en.2002-220228","type":"journal-article","created":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T03:21:30Z","timestamp":1030591290000},"page":"3671-3680","source":"Crossref","is-referenced-by-count":22,"title":["Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice"],"prefix":"10.1210","volume":"143","author":[{"given":"Erin L.","family":"Milliken","sequence":"first","affiliation":[{"name":"Departments of Pharmacology (E.L.M., R.K.A., M.D.L., A.B., R.A.K.), Case Western Reserve University, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Ameduri","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology (E.L.M., R.K.A., M.D.L., A.B., R.A.K.), Case Western Reserve University, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Landis","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology (E.L.M., R.K.A., M.D.L., A.B., R.A.K.), Case Western Reserve University, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Behrooz","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology (E.L.M., R.K.A., M.D.L., A.B., R.A.K.), Case Western Reserve University, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi W.","family":"Abdul-Karim","sequence":"additional","affiliation":[{"name":"Pathology (F.W.A.-K.), Case Western Reserve University, Cleveland, Ohio 44106"},{"name":"Department of Pathology (F.W.A.-K.), University Hospitals of Cleveland, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Keri","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology (E.L.M., R.K.A., M.D.L., A.B., R.A.K.), Case Western Reserve University, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122064118500_R1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/gad.12.4.449","article-title":"Think globally, act locally: the making of a mouse mammary gland.","volume":"12","author":"Hennighausen","year":"1998","journal-title":"Genes Dev"},{"key":"2019041122064118500_R2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200002243420807","article-title":"Assessing the risk of breast cancer.","volume":"342","author":"Armstrong","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041122064118500_R3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02841869209088901","article-title":"Reproductive factors in breast cancer epidemiology.","volume":"31","author":"Kvale","year":"1992","journal-title":"Acta Oncol"},{"key":"2019041122064118500_R4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/02841869409098400","article-title":"Does early physical maturity influence breast cancer risk?","volume":"33","author":"Stoll","year":"1994","journal-title":"Acta Oncol"},{"key":"2019041122064118500_R5","first-page":"1035","article-title":"Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian Republic.","volume":"69","author":"MacMahon","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0959-8049(98)00343-8","article-title":"The risk of breast cancer following reproductive surgery.","volume":"35","author":"Kreiger","year":"1999","journal-title":"Eur J Cancer"},{"key":"2019041122064118500_R7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/1097-0142(19881015)62:8<1625::AID-CNCR2820620828>3.0.CO;2-K","article-title":"Menstrual factors and breast cancer risk.","volume":"62","author":"Kvale","year":"1988","journal-title":"Cancer"},{"key":"2019041122064118500_R8","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.96.5.2520","article-title":"Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.","volume":"96","author":"Guzman","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"2019041122064118500_R9","first-page":"81","article-title":"Differentiation and breast cancer","volume":"57","author":"Russo","year":"1997","journal-title":"Medicina (B Aires)"},{"key":"2019041122064118500_R10","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/carcin\/16.11.2847","article-title":"Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?","volume":"16","author":"Thordarson","year":"1995","journal-title":"Carcinogenesis"},{"key":"2019041122064118500_R11","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","journal-title":"Lancet"},{"key":"2019041122064118500_R12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1018712905244","article-title":"The comparative pathology of human and mouse mammary glands.","volume":"4","author":"Cardiff","year":"1999","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041122064118500_R14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.onc.1203276","article-title":"MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.","volume":"19","author":"Callahan","year":"2000","journal-title":"Oncogene"},{"key":"2019041122064118500_R15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/carcin\/14.1.29","article-title":"Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.","volume":"14","author":"Tennant","year":"1993","journal-title":"Carcinogenesis"},{"key":"2019041122064118500_R16","first-page":"600","article-title":"Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.","volume":"57","author":"Hundley","year":"1997","journal-title":"Cancer Res"},{"key":"2019041122064118500_R17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.","volume":"369","author":"Wang","year":"1994","journal-title":"Nature"},{"key":"2019041122064118500_R18","first-page":"4413","article-title":"Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.","volume":"52","author":"Lin","year":"1992","journal-title":"Cancer Res"},{"key":"2019041122064118500_R19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnci\/58.4.1087","article-title":"Lack of growth of a pregnancy-dependent mouse mammary tumor (TPDMT-4) in the absence of pituitary hormones.","volume":"58","author":"Matsuzawa","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R20","first-page":"1598","article-title":"Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2\u03b1, 3\u03b1-epithio-5\u03b1-androstan-17\u03b2-ol (10275-S).","volume":"36","author":"Matsuzawa","year":"1976","journal-title":"Cancer Res"},{"key":"2019041122064118500_R21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/carcin\/15.7.1341","article-title":"Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation.","volume":"15","author":"Swanson","year":"1994","journal-title":"Carcinogenesis"},{"key":"2019041122064118500_R22","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.","volume":"100","author":"Wennbo","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041122064118500_R23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1095\/biolreprod57.5.1202","article-title":"Presence of functional luteinizing hormone\/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer.","volume":"57","author":"Lojun","year":"1997","journal-title":"Biol Reprod"},{"key":"2019041122064118500_R24","first-page":"857","article-title":"Luteinizing hormone\/human chorionic gonadotropin receptors in breast cancer.","volume":"57","author":"Meduri","year":"1997","journal-title":"Cancer Res"},{"key":"2019041122064118500_R25","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/endo.140.6.6634","article-title":"A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice.","volume":"140","author":"Raafat","year":"1999","journal-title":"Endocrinology"},{"key":"2019041122064118500_R26","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1210\/endo.141.8.7609","article-title":"Induction of mammary gland development in estrogen receptor-\u03b1 knockout mice.","volume":"141","author":"Bocchinfuso","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122064118500_R27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","article-title":"Estrogen receptor null mice: what have we learned and where will they lead us?","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041122064118500_R28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jnci\/92.11.903","article-title":"Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.","volume":"92","author":"Klijn","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-4731(85)80029-7","article-title":"LHRH-agonist treatment in clinical and experimental human breast cancer.","volume":"23","author":"Klijn","year":"1985","journal-title":"J Steroid Biochem"},{"key":"2019041122064118500_R30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.2001.19.2.343","article-title":"Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.","volume":"19","author":"Klijn","year":"2001","journal-title":"J Clin Oncol"},{"key":"2019041122064118500_R31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1073\/pnas.92.5.1322","article-title":"Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.","volume":"92","author":"Risma","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122064118500_R32","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/endo.140.6.6927","article-title":"Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure.","volume":"140","author":"Mann","year":"1999","journal-title":"Endocrinology"},{"key":"2019041122064118500_R33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1172\/JCI7716","article-title":"Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.","volume":"105","author":"Kero","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041122064118500_R34","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1210\/endo.138.8.5313","article-title":"Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology.","volume":"138","author":"Risma","year":"1997","journal-title":"Endocrinology"},{"key":"2019041122064118500_R35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1073\/pnas.97.1.383","article-title":"Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition.","volume":"97","author":"Keri","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122064118500_R36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/mend-5-5-725","article-title":"Estradiol inhibits transcription of the human glycoprotein hormone \u03b1-subunit gene despite the absence of a high affinity binding site for estrogen receptor.","volume":"5","author":"Keri","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2019041122064118500_R37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4615-4295-7_7","article-title":"Preparing mammary gland whole mounts from mice","volume-title":"Methods in mammary gland biology and breast cancer research","author":"Rasmussen","year":"2000"},{"key":"2019041122064118500_R38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10520299709096524","article-title":"Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval.","volume":"72","author":"Katoh","year":"1997","journal-title":"Biotech Histochem"},{"key":"2019041122064118500_R39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/joe.0.1710075","article-title":"Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation.","volume":"171","author":"Sivaraman","year":"2001","journal-title":"J Endocrinol"},{"key":"2019041122064118500_R40","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1242\/dev.121.7.2079","article-title":"Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation.","volume":"121","author":"Robinson","year":"1995","journal-title":"Development"},{"key":"2019041122064118500_R41","first-page":"1363","article-title":"Adenohypophyseal hormones and their hypothalamic releasing factors","volume-title":"Goodman, Gilman\u2019s the pharmacological basis of therapeutics","author":"Ascoli","year":"1996"},{"key":"2019041122064118500_R42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/carcin\/11.10.1849","article-title":"Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis.","volume":"11","author":"Russo","year":"1990","journal-title":"Carcinogenesis"},{"key":"2019041122064118500_R43","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/carcin\/18.9.1799","article-title":"Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death.","volume":"18","author":"Srivastava","year":"1997","journal-title":"Carcinogenesis"},{"key":"2019041122064118500_R44","first-page":"261","article-title":"Structure of the lutropin\/choriogonadotropin receptor.","volume":"46","author":"Segaloff","year":"1990","journal-title":"Recent Prog Horm Res"},{"key":"2019041122064118500_R45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0024-3205(97)00073-8","article-title":"The presence of luteinizing hormone\/human chorionic gonadotropin receptors in lactating rat mammary glands.","volume":"60","author":"Tao","year":"1997","journal-title":"Life Sci"},{"key":"2019041122064118500_R46","first-page":"1449","article-title":"Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the \u03b1-subunit gene to gonadotropin-releasing hormone and estrogens.","volume":"13","author":"Abbud","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041122064118500_R47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199407073310102","article-title":"Transient increase in the risk of breast cancer after giving birth.","volume":"331","author":"Lambe","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041122064118500_R48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0959-8049(94)90125-2","article-title":"Dual effect of parity on breast cancer risk","volume":"30A","author":"Hsieh","year":"1994","journal-title":"Eur J Cancer"},{"key":"2019041122064118500_R49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.onc.1203277","article-title":"The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.","volume":"19","author":"Cardiff","year":"2000","journal-title":"Oncogene"},{"key":"2019041122064118500_R50","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1073\/pnas.92.9.3650","article-title":"Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.","volume":"92","author":"Nandi","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122064118500_R51","first-page":"3692","article-title":"Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.","volume":"82","author":"Ormandy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122064118500_R52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bjc.1990.346","article-title":"Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.","volume":"62","author":"De Placido","year":"1990","journal-title":"Br J Cancer"},{"key":"2019041122064118500_R53","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1989.7.10.1474","article-title":"The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.","volume":"7","author":"Rutqvist","year":"1989","journal-title":"J Clin Oncol"},{"key":"2019041122064118500_R54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1989.7.8.1113","article-title":"Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.","volume":"7","author":"Kaufmann","year":"1989","journal-title":"J Clin Oncol"},{"key":"2019041122064118500_R55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.2910440506","article-title":"Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood.","volume":"44","author":"Apter","year":"1989","journal-title":"Int J Cancer"},{"key":"2019041122064118500_R56","first-page":"1395","article-title":"Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland.","volume":"6","author":"Grubbs","year":"1986","journal-title":"Anticancer Res"},{"key":"2019041122064118500_R57","first-page":"625","article-title":"N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells.","volume":"71","author":"Grubbs","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R58","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jnci\/82.15.1286","article-title":"Human chorionic gonadotropin and rat mammary cancer prevention.","volume":"82","author":"Russo","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R59","first-page":"783","article-title":"Does full-term pregnancy at a young age protect women against breast cancer through hCG?","volume":"96","author":"Rao","year":"2000","journal-title":"Obstet Gynecol"},{"key":"2019041122064118500_R60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/jnci\/91.11.967","article-title":"Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands.","volume":"91","author":"Medina","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2019041122064118500_R61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1026344707161","article-title":"Lactation and breast cancer risk.","volume":"2","author":"Newcomb","year":"1997","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041122064118500_R62","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1054\/bjoc.2001.1793","article-title":"Lactation and breast cancer risk: a case-control study in Connecticut.","volume":"84","author":"Zheng","year":"2001","journal-title":"Br J Cancer"},{"key":"2019041122064118500_R63","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/aje\/152.12.1129","article-title":"Lactation reduces breast cancer risk in Shandong Province, China.","volume":"152","author":"Zheng","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"2019041122064118500_R64","first-page":"474","article-title":"Lactation and the risk of breast cancer","volume":"27","author":"Purwanto","year":"2000","journal-title":"Gan To Kagaku Ryoho"},{"key":"2019041122064118500_R65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/bjc.1988.88","article-title":"Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy.","volume":"57","author":"Sinha","year":"1988","journal-title":"Br J Cancer"},{"key":"2019041122064118500_R66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3835(86)90027-3","article-title":"Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB\/c female mice.","volume":"33","author":"Lanari","year":"1986","journal-title":"Cancer Lett"},{"key":"2019041122064118500_R67","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/endo-116-4-1440","article-title":"Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas.","volume":"116","author":"Huseby","year":"1985","journal-title":"Endocrinology"},{"key":"2019041122064118500_R68","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene.","volume":"16","author":"Horseman","year":"1997","journal-title":"EMBO J"},{"key":"2019041122064118500_R69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ijc.2910310312","article-title":"Progression of rat mammary development with age and its relationship to carcinogenesis by a chemical carcinogen.","volume":"31","author":"Sinha","year":"1983","journal-title":"Int J Cancer"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/143\/9\/3671\/9300843\/endo3671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:46:45Z","timestamp":1622098005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/143\/9\/3671\/2881151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2002-220228","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,1]]}}}